Cargando…
Large set data mining reveals overexpressed GPCRs in prostate and breast cancer: potential for active targeting with engineered anti-cancer nanomedicines
Over 800 G-protein-coupled receptors (GPCRs) are encoded by the human genome and many are overexpressed in tumors. GPCRs are triggered by ligand molecules outside the cell and activate internal signal transduction pathways driving cellular responses. The receptor signals are desensitized by receptor...
Autores principales: | Kübler, Eric, Albrecht, Hugo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5982759/ https://www.ncbi.nlm.nih.gov/pubmed/29861840 http://dx.doi.org/10.18632/oncotarget.25427 |
Ejemplares similares
-
Using GPCRs as Molecular Beacons to Target Ovarian Cancer with Nanomedicines
por: Khetan, Riya, et al.
Publicado: (2022) -
Systematic Meta-Analysis Identifies Co-Expressed Kinases and GPCRs in Ovarian Cancer Tissues Revealing a Potential for Targeted Kinase Inhibitor Delivery
por: Albrecht, Hugo, et al.
Publicado: (2019) -
Editorial: GPCRs and Cancer
por: Chen, Suzie
Publicado: (2017) -
Tumor-Infiltrating Lymphocytes in Localized Prostate Cancer: Do They Play an Important Role?
por: Vilaça, Marta, et al.
Publicado: (2023) -
Colon Cancer Metastatic to the Thyroid Gland in the Setting of Pathologically Diagnosed Papillary Thyroid Cancer: A Review and Report of a Case
por: Zafar, Imran, et al.
Publicado: (2020)